Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001172661-25-001219
Filing Date
2025-02-14
Accepted
2025-02-14 16:48:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8686
  Complete submission text file 0001172661-25-001219.txt   10426
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Subject) CIK: 0001874252 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93665 | Film No.: 25630248
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)